13 Einträge gefunden

1. Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" ( 72 h): findings from the MONITOR-GCSF study

   1. Ludwig, Heinz
   2. Gascón, Pere
   3. Bokemeyer, Carsten
   4. Aapro, Matti
   5. Boccadoro, Mario
   6. Denhaerynck, Kris
   7. Krendyukov, Andriy

   2019 - Forschungsinformationssystem des UKE
2. Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study

   1. Ludwig, Heinz
   2. Bokemeyer, Carsten
   3. Aapro, Matti
   4. Boccadoro, Mario
   5. Gascón, Pere
   6. Denhaerynck, Kris
   7. Krendyukov, Andriy

   2019 - Forschungsinformationssystem des UKE
3. Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study

   1. Bokemeyer, Carsten
   2. Gascón, Pere
   3. Aapro, Matti
   4. Ludwig, Heinz
   5. Boccadoro, Mario
   6. Denhaerynck, Kris
   7. Gorray, Michael

   2017 - Forschungsinformationssystem des UKE
4. Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study)

   1. Aapro, Matti
   2. Bokemeyer, Carsten
   3. Ludwig, Heinz
   4. Gascón, Pere
   5. Boccadoro, Mario
   6. Denhaerynck, Kris
   7. Gorray, Michael

   2016 - Forschungsinformationssystem des UKE
5. Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)

   1. Gascón, Pere
   2. Aapro, Matti
   3. Ludwig, Heinz
   4. Bokemeyer, Carsten
   5. Boccadoro, Mario
   6. Turner, Matthew
   7. Denhaerynck, Kris

   2016 - Forschungsinformationssystem des UKE
6. Erratum to: Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)

   1. Gascón, Pere
   2. Aapro, Matti
   3. Ludwig, Heinz
   4. Bokemeyer, Carsten
   5. Boccadoro, Mario
   6. Turner, Matthew
   7. Denhaerynck, Kris

   2015 - Forschungsinformationssystem des UKE
7. Modeling of treatment response to erythropoiesis-stimulating agents in older (age≥70years) and younger (age<70years) patients with cancer and anemia: findings from the Anemia Cancer Treatment study

   1. Abraham, Ivo
   2. MacDonald, Karen
   3. Tharmarajah, Soba
   4. Bokemeyer, Carsten
   5. Ludwig, Heinz
   6. Soubeyran, Pierre
   7. Battistel, Vittorio

   2013 - Forschungsinformationssystem des UKE
8. Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥ 10 g/dL: an exploratory analysis of a phase 3 trial.

   1. Canon, Jean-Luc
   2. Vansteenkiste, Johan
   3. Hedenus, Michael
   4. Gascon, Pere
   5. Bokemeyer, Carsten
   6. Ludwig, Heinz
   7. Vermorken, Jan

   2012 - Forschungsinformationssystem des UKE
9. Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study.

   1. Ludwig, Heinz
   2. Aapro, Matti
   3. Bokemeyer, Carsten
   4. Macdonald, Karen
   5. Soubeyran, Pierre
   6. Turner, Matthew
   7. Albrecht, Tara

   2009 - Forschungsinformationssystem des UKE
10. Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level <10 g/dL versus > or = 10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial.

    1. Vansteenkiste, Johan
    2. Hedenus, Michael
    3. Gascon, Pere
    4. Bokemeyer, Carsten
    5. Ludwig, Heinz
    6. Vermorken, Jan
    7. Hamilton, Lisa

    2009 - Forschungsinformationssystem des UKE - frei zugänglich
11. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer.

    1. Bokemeyer, Carsten
    2. Bondarenko, Igor
    3. Makhson, Anatoly
    4. Hartmann, Joerg T
    5. Aparicio, Jorge
    6. de Braud, Filippo
    7. Donea, Serban

    2009 - Forschungsinformationssystem des UKE
12. The background and methodology of the Anaemia Cancer Treatment (A.C.T.) study: a global retrospective study of practice patterns and outcomes in the management of anaemia in cancer patients and their congruence with evidence-based guidelines.

    1. Aapro, Matti
    2. Abraham, Ivo
    3. Bokemeyer, Carsten
    4. Ludwig, Heinz
    5. Macdonald, Karen
    6. Soubeyran, Pierre
    7. Turner, Matthew

    2008 - Forschungsinformationssystem des UKE
13. Erythropoietins should be used according to guidelines.

    1. Aapro, Matti S
    2. Birgegård, Gunnar
    3. Bokemeyer, Carsten
    4. Cornes, Paul
    5. Foubert, Jan
    6. Gascon, Pere
    7. Glaspy, John

    2008 - Forschungsinformationssystem des UKE